Daily aspirin no help for slowing hearing loss in healthy older people

Embargoed until: Publicly released: 2024-07-26 01:00

Australia; NSW; VIC

Image by HeungSoon from Pixabay

Taking a low-dose aspirin every day does not appear to impact the progression of age-related hearing loss in healthy older adults, according to Australian research. The study of almost 300 Aussies aged 70 years or older found that daily 100mg aspirin was no better than placebo for slowing age-related hearing loss. The researchers had hoped that aspirin might help delay hearing loss through its blood circulation and anti-inflammatory effects

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Monash University, The University of Melbourne, Macquarie University

Funder: The Aspirin in Reducing Events in the Elderly (ASPREE) trial has received funding from the National Institute on Aging/National Cancer Institute of the National Institutes of Health (grants U01AG029824 and U19AG062682); the National Health and Medical Research Council (NHMRC) of Australia; the Victorian Cancer Agency (Australia); and Monash University. ASPREE-Hearing has received funding from Monash University and the Deafness Foundation. Dr Rance holds the Graeme Clark Chair in Audiology and Speech Science at the University of Melbourne. Dr McNeil is supported by an NHMRC Leadership Fellowship (IG 1173690). Bayer AG (Germany) provided the trial drug (aspirin) and placebo

Media Contact/s

Contact details are only visible to registered journalists.